Stay updated with breaking news from Oncomap Extra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that new data presentations...
Ark launched a new fund on Sept. 27. While you try to figure it out, here are 7 cheap Cathie Wood stocks to buy for October.
In the signal-finding study currently enrolling colorectal and triple-negative breast cancer patients, the company will also evaluate the ability of its Xerna TME Panel to identify best responders.
Mirae Asset Global Investments Co. Ltd. raised its position in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 19.4% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 112,740 shares of the medical research company’s stock after buying an additional 18,357 shares during the quarter. Mirae Asset Global […]
Second quarter highlights Total second quarter revenue of $522 million, including Screening revenue of $354 million, Precision Oncology revenue of $154...